• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LY49Q,一种带有 ITIM 的 NK 受体,正向调节破骨细胞分化。

Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation.

机构信息

Department of Cell Signaling, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8549, Japan.

出版信息

Biochem Biophys Res Commun. 2010 Mar 12;393(3):432-8. doi: 10.1016/j.bbrc.2010.02.013. Epub 2010 Feb 12.

DOI:10.1016/j.bbrc.2010.02.013
PMID:20153723
Abstract

Osteoclasts, multinucleated cells that resorb bone, play a key role in bone remodeling. Although immunoreceptor tyrosine-based activation motif (ITAM)-mediated signaling is critical for osteoclast differentiation, the significance of immunoreceptor tyrosine-based inhibitory motif (ITIM) has not been well understood. Here we report the function of Ly49Q, an Ly49 family member possessing an ITIM motif, in osteoclastogenesis. Ly49Q is selectively induced by receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL) stimulation in bone marrow-derived monocyte/macrophage precursor cells (BMMs) among the Ly49 family of NK receptors. The knockdown of Ly49Q resulted in a significant reduction in the RANKL-induced formation of tartrate-resistance acid phosphatase (TRAP)-positive multinucleated cells, accompanied by a decreased expression of osteoclast-specific genes such as Nfatc1, Tm7sf4, Oscar, Ctsk, and Acp5. Osteoclastogenesis was also significantly impaired in Ly49Q-deficient cells in vitro. The inhibitory effect of Ly49Q-deficiency may be explained by the finding that Ly49Q competed for the association of Src-homology domain-2 phosphatase-1 (SHP-1) with paired immunoglobulin-like receptor-B (PIR-B), an ITIM-bearing receptor which negatively regulates osteoclast differentiation. Unexpectedly, Ly49Q deficiency did not lead to impaired osteoclast formation in vivo, suggesting the existence of a compensatory mechanism. This study provides an example in which an ITIM-bearing receptor functions as a positive regulator of osteoclast differentiation.

摘要

破骨细胞是一种多核细胞,负责吸收骨骼,在骨骼重塑中发挥着关键作用。尽管免疫受体酪氨酸激活基序 (ITAM) 介导的信号通路对于破骨细胞分化至关重要,但免疫受体酪氨酸抑制基序 (ITIM) 的意义尚未得到充分理解。在这里,我们报告了 Ly49Q(一种具有 ITIM 基序的 Ly49 家族成员)在破骨细胞生成中的功能。在核因子-κB 受体激活剂(RANKL)刺激下,骨髓来源的单核细胞/巨噬细胞前体细胞(BMM)中的 Ly49 家族 NK 受体中,Ly49Q 被选择性诱导。Ly49Q 的敲低导致 RANKL 诱导的抗酒石酸盐酸性磷酸酶(TRAP)阳性多核细胞形成显著减少,同时破骨细胞特异性基因如 Nfatc1、Tm7sf4、Oscar、Ctsk 和 Acp5 的表达降低。体外 Ly49Q 缺陷细胞中的破骨细胞生成也受到显著抑制。Ly49Q 缺陷的抑制作用可能是由于发现 Ly49Q 与 Src 同源结构域-2 磷酸酶-1(SHP-1)竞争结合配对免疫球蛋白样受体-B(PIR-B),PIR-B 是一种具有 ITIM 的受体,可负向调节破骨细胞分化。出乎意料的是,Ly49Q 缺陷并不导致体内破骨细胞形成受损,这表明存在代偿机制。本研究提供了一个例证,即具有 ITIM 的受体可作为破骨细胞分化的正调控因子。

相似文献

1
Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation.LY49Q,一种带有 ITIM 的 NK 受体,正向调节破骨细胞分化。
Biochem Biophys Res Commun. 2010 Mar 12;393(3):432-8. doi: 10.1016/j.bbrc.2010.02.013. Epub 2010 Feb 12.
2
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.新型NF-κB抑制剂(-)-DHMEQ通过下调NFATc1抑制RANKL诱导的破骨细胞生成。
J Bone Miner Res. 2005 Apr;20(4):653-62. doi: 10.1359/JBMR.041213. Epub 2004 Dec 6.
3
Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.表皮生长因子受体通过与RANK信号通路相互作用来调节破骨细胞的分化和存活。
J Cell Physiol. 2008 Nov;217(2):409-22. doi: 10.1002/jcp.21511.
4
Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture.Ly49Q是Ly49家族的成员之一,在髓系谱系细胞上选择性表达,并参与细胞骨架结构的调节。
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):1016-21. doi: 10.1073/pnas.0305400101. Epub 2004 Jan 19.
5
TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.TRAF2对于肿瘤坏死因子-α诱导的破骨细胞生成至关重要。
J Bone Miner Res. 2005 May;20(5):840-7. doi: 10.1359/JBMR.041225. Epub 2004 Dec 20.
6
The mechanism of osteoclast differentiation induced by IL-1.白细胞介素-1诱导破骨细胞分化的机制。
J Immunol. 2009 Aug 1;183(3):1862-70. doi: 10.4049/jimmunol.0803007. Epub 2009 Jul 8.
7
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.成纤维细胞样基质细胞表达核因子κB受体活化因子配体并支持破骨细胞分化。
J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459.
8
Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.Jun二聚化蛋白2(JDP2)是转录因子AP-1家族的成员,介导RANKL诱导的破骨细胞分化。
J Exp Med. 2003 Apr 21;197(8):1029-35. doi: 10.1084/jem.20021321.
9
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.肿瘤坏死因子配体家族的一个新成员,骨保护素配体/破骨细胞分化因子/肿瘤坏死因子相关激活诱导因子/核因子κB受体活化因子配体,调节破骨细胞的分化和功能。
Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252.
10
MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR.MHC 类 II 转录激活因子通过下调 NFATc1 和 OSCAR 负调控 RANKL 介导的破骨细胞分化。
Cell Signal. 2010 Sep;22(9):1341-9. doi: 10.1016/j.cellsig.2010.05.001. Epub 2010 May 11.

引用本文的文献

1
Protein tyrosine phosphatases in skeletal development and diseases.骨骼发育与疾病中的蛋白质酪氨酸磷酸酶
Bone Res. 2022 Jan 28;10(1):10. doi: 10.1038/s41413-021-00181-x.
2
Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway.韦地洛酮通过调节 Wnt/β-连环蛋白信号通路增强成骨细胞生成,通过 NF-κB/c-fos/NFATc1 通路抑制破骨细胞生成。
Sci Rep. 2016 Aug 25;6:32260. doi: 10.1038/srep32260.
3
A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
破骨细胞免疫受体调控的综合综述
Clin Rev Allergy Immunol. 2016 Aug;51(1):48-58. doi: 10.1007/s12016-015-8521-8.
4
Aryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass.破骨细胞谱系细胞中的芳烃受体是骨量的负调节因子。
PLoS One. 2015 Jan 23;10(1):e0117112. doi: 10.1371/journal.pone.0117112. eCollection 2015.
5
Ly49 receptors: innate and adaptive immune paradigms.Ly49受体:先天性和适应性免疫模式
Front Immunol. 2014 Apr 2;5:145. doi: 10.3389/fimmu.2014.00145. eCollection 2014.
6
Osteoimmunology: the expanding role of immunoreceptors in osteoclasts and bone remodeling.骨免疫学:免疫受体在破骨细胞和骨重塑中的作用不断扩展
Bonekey Rep. 2012 Apr 18;1. doi: 10.1038/bonekey.2012.59.
7
The ly49 gene family. A brief guide to the nomenclature, genetics, and role in intracellular infection.LY49 基因家族。命名法、遗传学及其在细胞内感染中的作用简介。
Front Immunol. 2013 Apr 16;4:90. doi: 10.3389/fimmu.2013.00090. eCollection 2013.
8
TLT-1s, alternative transcripts of triggering receptor expressed on myeloid cell-like transcript-1 (TLT-1), Inhibits the triggering receptor expressed on myeloid cell-2 (TREM-2)-mediated signaling pathway during osteoclastogenesis.TLT-1s 是髓样细胞触发受体样转录物-1(TLT-1)的替代转录本,在破骨细胞发生过程中抑制髓样细胞触发受体-2(TREM-2)介导的信号通路。
J Biol Chem. 2012 Aug 24;287(35):29620-6. doi: 10.1074/jbc.M112.351239. Epub 2012 Jul 3.
9
Osteoprotection by semaphorin 3A.信号蛋白 3A 的护骨作用。
Nature. 2012 May 3;485(7396):69-74. doi: 10.1038/nature11000.
10
Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).树突状细胞特异性跨膜蛋白(DC-STAMP)对人破骨细胞发育的调节作用。
J Bone Miner Res. 2012 Jan;27(1):79-92. doi: 10.1002/jbmr.531.